Targeted gene disruption to cure HIV

Current Opinion in HIV and AIDS

Volumn 8, Issue 3, 2013, Pages 217-223

  Stone, Daniel ^a   Kiem, Hans Peter ^a   Jerome, Keith R ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

gene targeting; homing endonuclease; reservoir; TALEN; zinc finger nuclease

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; CRE RECOMBINASE; ENDONUCLEASE; EXONUCLEASE; NUCLEASE; RECOMBINASE; SITE SPECIFIC RECOMBINASE; TRANSCRIPTION ACTIVATOR LIKE EFFECTOR NUCLEASE; UNCLASSIFIED DRUG; ZINC FINGER NUCLEASE;

CELL MATURATION; DNA SEQUENCE; ESSENTIAL GENE; GENE DELIVERY SYSTEM; GENE DISRUPTION; GENE TARGETING; HEMATOPOIETIC CELL; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOMA; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ENGINEERING; REVIEW; T LYMPHOCYTE; TARGETED GENE DISRUPTION; VIRUS GENE; VIRUS GENOME; VIRUS PATHOGENESIS; VIRUS REPLICATION; ZINC FINGER MOTIF;

ENDONUCLEASES; GENE TARGETING; HIV INFECTIONS; HUMANS;

EID: 84876407799     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e32835f736c     Document Type: Review

References (52)

1. McElrath MJ, Haynes BF. Induction of immunity to human immunodeficiency virus type-1 by vaccination. Immunity 2010; 33:542-554; doi: 10.1016/j.immuni.2010.09.011. PubMed PMID: 21029964. PubMed Central PMCID: PMC3031162.
2. + T-cell immune correlates against HIV. Immunol Rev 2011; 239:109-124; doi: 10.1111/j.1600-065X.2010.00968.x. PubMed PMID: 21198668. PubMed Central PMCID: PMC3025661.
3. + cell responses following allogeneic hematopoietic cell transplantation. Blood 2008; 112:3484-3487; doi: 10.1182/blood-2008-05- 157511. PubMed PMID: 18698002. PubMed Central PMCID: PMC2569185.
4. Thompson S, Clarke AR, Pow AM, et al. Germ line transmission and expression of a corrected HPRT gene produced by gene targeting in embryonic stem cells. Cell 1989; 56:313-321; PubMed PMID: 2912572.
5. Thomas KR, Capecchi MR. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 1987; 51:503-512; PubMed PMID: 2822260.
6. Hockemeyer D, Jaenisch R. Gene targeting in human pluripotent cells. Cold Spring Harb Symp Quant Biol 2010; 75:201-209; doi: 10.1101/sqb.2010.75.021. PubMed PMID: 21209393.
7. Schiffer JT, Aubert M, Weber ND, et al. Targeted DNA mutagenesis for the cure of chronic viral infections. J Virol 2012; 86:8920-8936; doi: 10.1128/JVI.00052-12. PubMed PMID: 22718830. PubMed Central PMCID: PMC3416169.
8. Carroll D. Genome engineering with zinc-finger nucleases. Genetics 2011; 188:773-782; doi: 10.1534/genetics.111.131433. PubMed PMID: 21828278. PubMed Central PMCID: PMC3176093.
9. Handel EM, Cathomen T. Zinc-finger nuclease based genome surgery: it's all about specificity. Curr Gene Ther 2011; 11:28-37; PubMed PMID: 21182467.
10. Miller JC, Holmes MC, Wang J, et al. An improved zinc-finger nuclease architecture for highly specific genome editing. Nat Biotechnol 2007; 25:778-785; doi: 10.1038/nbt1319. PubMed PMID: 17603475.
11. Szczepek M, Brondani V, Buchel J, et al. Structure-based redesign of the dimerization interface reduces the toxicity of zinc-finger nucleases. Nat Biotechnol 2007; 25:786-793; doi: 10.1038/nbt1317. PubMed PMID: 17603476.
12. Moscou MJ, Bogdanove AJ. A simple cipher governs DNA recognition by TAL effectors. Science 2009; 326:1501; doi: 10.1126/science.1178817. PubMed PMID: 19933106.
13. Boch J, Scholze H, Schornack S, et al. Breaking the code of DNA binding specificity of TAL-type III effectors. Science 2009; 326:1509-1512; doi: 10.1126/science.1178811. PubMed PMID: 19933107.
14. Christian M, Cermak T, Doyle EL, et al. Targeting DNA double-strand breaks with TAL effector nucleases. Genetics 2010; 186:757-761; doi: 10.1534/genetics.110.120717. PubMed PMID: 20660643. PubMed Central PMCID: PMC2942870.
15. Li T, Huang S, Jiang WZ, et al. TAL nucleases (TALNs): hybrid proteins composed of TAL effectors and FokI DNA-cleavage domain. Nucleic Acids Res 2011; 39:359-372; doi: 10.1093/nar/gkq704. PubMed PMID: 20699274. PubMed Central PMCID: PMC3017587.
16. Miller JC, Tan S, Qiao G, et al. A TALE nuclease architecture for efficient genome editing. Nat Biotechnol 2011; 29:143-148; doi: 10.1038/nbt.1755. PubMed PMID: 21179091.
17. Hockemeyer D, Wang H, Kiani S, et al. Genetic engineering of human pluripotent cells using TALE nucleases. Nat Biotechnol 2011; 29:731-734; doi: 10.1038/nbt.1927. PubMed PMID: 21738127. PubMed Central PMCID: PMC3152587.
18. Sun N, Liang J, Abil Z, Zhao H. Optimized TAL effector nucleases (TALENs) for use in treatment of sickle cell disease. Mol Biosyst 2012; 8:1255-1263; doi: 10.1039/c2mb05461b. PubMed PMID: 22301904.
19. Stoddard BL. Homing endonucleases: from microbial genetic invaders to reagents for targeted DNA modification. Structure 2011; 19:7-15; doi: 10.1016/j.str.2010.12.003. PubMed PMID: 21220111. PubMed Central PMCID: PMC3038549.
20. Takeuchi R, Lambert AR, Mak AN, et al. Tapping natural reservoirs of homing endonucleases for targeted gene modification. Proc Natl Acad Sci USA 2011; 108:13077-13082; doi: 10.1073/pnas.1107719108. PubMed PMID: 21784983. PubMed Central PMCID: PMC3156218.
21. Arnould S, Perez C, Cabaniols JP, et al. Engineered I-CreI derivatives cleaving sequences from the human XPC gene can induce highly efficient gene correction in mammalian cells. J Mol Biol 2007; 371:49-65; doi: 10.1016/j.jmb.2007.04.079. PubMed PMID: 17561112.
22. Grizot S, Smith J, Daboussi F, et al. Efficient targeting of a SCID gene by an engineered single-chain homing endonuclease. Nucleic Acids Res 2009; 37:5405-5419; doi: 10.1093/nar/gkp548. PubMed PMID: 19584299. PubMed Central PMCID: PMC2760784.
23. Chapdelaine P, Pichavant C, Rousseau J, et al. Meganucleases can restore the reading frame of a mutated dystrophin. Gene Ther 2010; 17:846-858; doi: 10.1038/gt.2010.26. PubMed PMID: 20393509.
24. Grosse S, Huot N, Mahiet C, et al. Meganuclease-mediated inhibition of HSV1 Infection in cultured cells. Mol Ther 2011; 19:694-702; doi: 10.1038/mt.2010.302. PubMed PMID: 21224832. PubMed Central PMCID: PMC3070101.
25. Gao H, Smith J, Yang M, et al. Heritable targeted mutagenesis in maize using a designed endonuclease. Plant J 2010; 61:176-187; doi: 10.1111/j.1365-313X.2009.04041.x. PubMed PMID: 19811621.
26. Redondo P, Prieto J, Munoz IG, et al. Molecular basis of xeroderma pigmen-tosum group C DNA recognition by engineered meganucleases. Nature 2008; 456:107-111; doi: 10.1038/nature07343. PubMed PMID: 18987743.
27. Doyon JB, Pattanayak V, Meyer CB, Liu DR. Directed evolution and substrate specificity profile of homing endonuclease I-SceI. J Am Chem Soc 2006; 128:2477-2484; doi: 10.1021/ja057519l. PubMed PMID: 16478204.
28. Certo MT, Gwiazda KS, Kuhar R, et al. Coupling endonucleases with DNA end-processing enzymes to drive gene disruption. Nat Methods 2012;9:973-975; doi: 10.1038/nmeth.2177. PubMed PMID: 22941364.
29. Bennardo N, Gunn A, Cheng A, et al. Limiting the persistenceofa chromosome break diminishes its mutagenic potential. PLoS Genet 2009; 5:e1000683; doi: 10.1371/journal.pgen.1000683. PubMed PMID: 19834534. PubMed Central PMCID: PMC2752804.
30. Turan S, Bode J. Site-specific recombinases: from tag-and-target-to tag-and-exchange-based genomic modifications. FASEB J 2011; 25:4088-4107; doi: 10.1096/fj.11-186940. PubMed PMID: 21891781.
31. Kiem HP, Jerome KR, Deeks SG, McCune JM. Hematopoietic-stem-cell-based gene therapy for HIV disease. Cell Stem Cell 2012; 10:137-147; doi: 10.1016/j.stem.2011.12.015. PubMed PMID: 22305563. PubMed Central PMCID: PMC3274769.
32. Telenti A. Safety concerns about CCR5 as an antiviral target. Curr Opin HIV AIDS 2009; 4:131-135; doi: 10.1097/COH.0b013e3283223d76. PubMed PMID: 19339952.
33. Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996; 382:722-725; doi: 10.1038/382722a0. PubMed PMID: 8751444.
34. Allers K, Hutter G, Hofmann J, et al. Evidence for the cure of HIV infection by CCR5Delta32/Delta32 stem cell transplantation. Blood 2011; 117:2791-2799; doi: 10.1182/blood-2010-09-309591. PubMed PMID: 21148083.
35. Hutter G, Nowak D, Mossner M, et al. Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med 2009; 360:692-698; doi: 10.1056/NEJMoa0802905. PubMed PMID: 19213682.
36. + cells from CCR5-disrupted human embryonic and induced pluripotent stem cells. Hum Gene Ther 2012; 23:238-242; doi: 10.1089/hum.2011.126. PubMed PMID: 21981760.
37. + T cells by genome editing using zinc-finger nucleases. Nat Biotechnol 2008; 26:808-816; doi: 10.1038/nbt1410. PubMed PMID: 18587387.
38. Holt N, Wang J, Kim K, et al. Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat Biotechnol 2010; 28:839-847; doi: 10.1038/nbt. 1663. PubMed PMID: 20601939. PubMed Central PMCID: PMC3080757.
39. Schleifman EB, Bindra R, Leif J, et al. Targeted disruption of the CCR5 gene in human hematopoietic stem cells stimulated by peptide nucleic acids. Chem Biol 2011; 18:1189-1198; doi: 10.1016/j.chembiol.2011.07.010. PubMed PMID: 21944757. PubMed Central PMCID: PMC3183429.
40. Kawabata K, Ujikawa M, Egawa T, et al. A cell-autonomous requirement for CXCR4 in long-term lymphoid and myeloid reconstitution. Proc Natl Acad Sci USA 1999; 96:5663-5667; PubMed PMID: 10318941. PubMed Central PMCID: PMC21917.
41. Nagasawa T, Nakajima T, Tachibana K, et al. Molecular cloning and characterization of a murine pre-B-cell growth-stimulating factor/stromal cell-derived factor 1 receptor, a murine homolog of the human immunodeficiency virus 1 entry coreceptor fusin. Proc Natl Acad Sci USA 1996; 93:14726-14729; PubMed PMID: 8962122. PubMed Central PMCID: PMC26203.
42. +T cells with CXCR4-specific zinc-finger nucleases. PLoS Pathog 2011;7:e1002020; doi: 10.1371/journal.ppat.1002020. PubMed PMID:21533216. PubMed Central PMCID: PMC3077364.
43. Yuan J, Wang J, Crain K, et al. Zinc-finger nuclease editing of human cxcr4 promotes HIV-1 CD4(+) T cell resistance and enrichment. Mol Ther 2012;20:849-859; doi: 10.1038/mt.2011.310. PubMed PMID: 22273578. PubMed Central PMCID: PMC3321595.
44. + T cells from peripheral blood of HIV-1-infected individuals contain only one HIV DNA molecule. Proc Natl Acad Sci USA 2011; 108:11199-11204; doi: 10.1073/pnas.1107729108. PubMed PMID: 21690402. PubMed Central PMCID: PMC3131354.
45. Chen BK, Gandhi RT, Baltimore D. CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef. J Virol 1996; 70:6044-6053; PubMed PMID: 8709227. PubMed Central PMCID: PMC190625.
46. Cradick TJ, Keck K, Bradshaw S, et al. Zinc-finger nucleases as a novel therapeutic strategy for targeting hepatitis B virus DNAs. Mol Ther 2010; 18:947-954; doi: 10.1038/mt.2010.20. PubMed PMID: 20160705. PubMed Central PMCID: PMC2890117.
47. Aubert M, Ryu BY, Banks L, et al. Successful targeting and disruption of an integrated reporter lentivirus using the engineered homing endonu-clease Y2 I-AniI. PLoS One 2011; 6:e16825; doi: 10.1371/journal.pone.0016825. PubMed PMID: 21399673. PubMed Central PMCID:PMC3036713.
48. Flowers CC, Woffendin C, Petryniak J, et al. Inhibition of recombinant human immunodeficiency virus type 1 replication by a site-specific recombinase. J Virol 1997; 71:2685-2692; PubMed PMID: 9060621. PubMed Central PMCID: PMC191390.
49. Lee YS, Kim ST, Kim GW, et al. An engineered lox sequence containing part of a long terminal repeat of HIV-1 permits Cre recombinase-mediated DNA excision. Biochem Cell Biol 2000; 78:653-658; PubMed PMID: 11206575.
50. Lee Y, Park J. A novel mutant loxP containing part of long terminal repeat of HIV-1 in spacer region: presentation of possible target site for antiviral strategy using site-specific recombinase. Biochem Biophys Res Commun 1998; 253:588-593; PubMed PMID: 9918772.
51. Mariyanna L, Priyadarshini P, Hofmann-Sieber H, et al. Excision of HIV-1 proviral DNA by recombinant cell permeable tre-recombinase. PLoS One 2012; 7:e31576; doi: 10.1371/journal.pone.0031576. PubMed PMID:22348110. PubMed Central PMCID: PMC3278460.
52. Sarkar I, Hauber I, Hauber J, Buchholz F. HIV-1 proviral DNA excision using an evolved recombinase. Science 2007; 316:1912-1915; doi: 10.1126/science.1141453. PubMed PMID: 17600219.